Filing Details

Accession Number:
0001225208-24-002654
Form Type:
4
Zero Holdings:
No
Publication Time:
2024-02-21 17:52:11
Reporting Period:
2024-02-21
Accepted Time:
2024-02-21 17:52:11
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1099800 Edwards Lifesciences Corp EW Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) 364316614
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1740963 Daveen Chopra One Edwards Way
Irvine CA 92614
Cvp, Tmtt No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2024-02-21 7,000 $59.26 30,950 No 4 M Direct
Common Stock Disposition 2024-02-21 1,200 $86.67 29,750 No 4 S Direct
Common Stock Disposition 2024-02-21 7,000 $86.75 22,750 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Employee Stock Option (Right to Acquire) Disposition 2024-02-21 7,000 $0.00 7,000 $59.26
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2020-05-08 2026-05-07 No 4 M Direct
Footnotes
  1. This transaction was executed in multiple trades at prices ranging from $86.6600 to $86.6800. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
  2. This transaction was executed in multiple trades at prices ranging from $86.7455 to $86.7600. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, upon request by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.